Markets

Inovio tanks 40% after pausing coronavirus vaccine trial, trading halted

Inovio Pharmaceuticals tumbled as much as 40% in early Monday trading after the biotech firm announced a temporary hold on its coronavirus vaccine’s phase 2/3 trial. The study is on “partial clinical hold” until questions asked by the Food and Drug Administration are answered, Inovio said in a press release. […]
Inovio tanks 40% after pausing coronavirus vaccine trial, trading halted